Secnidazole for use in the treatment of trichomoniasis
US11324721B2 · kind B2 · utility
0Cited by
43References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 2020 |
| Grant date | May 10, 2022 |
| Priority date | — |
| Expiry date | Jun 2, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D233/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Embodiments are directed to secnidazole formulations and the use of a secnidazole formulation for the treatment of trichomoniasis in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.